Novetide is one of the world's leading manufacturers of peptides for the pharmaceutical industry.
Our two FDA approved production sites have flexible and scalable manufacturing capability ranging from grams to tons. Novetide's peptides are currently sold to multinational pharmaceutical companies, start-up companies and researchers worldwide.
This experience combined with our commitment to excellence and innovation, enables us to provide cutting edge peptide solutions to our customers worldwide.
The Novetide guarantee:
Novetide's outstanding R&D capability is another important factor in our ability to provide innovative and cost effective peptide solutions. Our R&D team has decades of proven peptide experience and has access to a world class R&D infrastructure at the IMI corporate R&D center of Israel Chemicals (ICL). This infrastructure includes analytical laboratories, equipment, techniques and support with organic synthesis. ICL, a Novetide shareholder, is a world leading fertilizer and Specialty Chemicals Company.
We have a wide range of commercial products and the experience needed to take your peptide from the early R&D stages through to commercialization. 100% peptide focus, experience, expertise, innovation, and commitment to excellence all combine to make Novetide your perfect Peptide Partner.